Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.
Market Dynamics
Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.
Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.
Key features of the study:
This report provides in-depth analysis of the Asia Pacific newborn screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Asia Pacific newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The Asia Pacific newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for Asia Pacific newborn screening market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Asia Pacific Newborn Screening Market, By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
Asia Pacific Newborn Screening Market, By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
Asia Pacific Newborn Screening Market, By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Asia Pacific Newborn Screening Market, By Region:
China
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
India
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Japan
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Australia
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
South Korea
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
ASEAN
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Rest of Asia Pacific
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Company Profiles
Medtronic plc*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-rad Laboratories, Inc.
GE Healthcare
PerkinElmer, Inc.
Waters Technologies Corporation
Masimo Corporation
Natus Medical Inc.
Trivitron Healthcare Pvt. Ltd.
ZenTech S.A.
Agilent Technologies, Inc.
Danaher Corporation (AB SCIEX)
“*” marked represents similar segmentation in other categories in the respective section.